Management of the adverse events of afatinib: a consensus of the recommendations of the Spanish expert panel.
暂无分享,去创建一个
E. Esteban | N. Reguart | R. García-Campelo | M. Cobo | Á. Artal | E. Arriola | M. García-Muret | M. Rodríguez
暂无分享,去创建一个
E. Esteban | N. Reguart | R. García-Campelo | M. Cobo | Á. Artal | E. Arriola | M. García-Muret | M. Rodríguez